Newsroom | 2195 results
Sorted by: Latest
-
American Osteopathic Association Celebrates Top Rankings for Osteopathic Medical Education in U.S. News & World Report Rankings
CHICAGO--(BUSINESS WIRE)--Newly released rankings from U.S. News & World Report underscore the significant role osteopathic medical schools play in preparing physicians to serve in high-need areas across the country. The latest data show that colleges of osteopathic medicine (COMs) continue to distinguish themselves in graduating Doctor(s) of Osteopathic Medicine (DOs) who enter primary care and practice in rural and medically underserved communities. According to the rankings: Osteopathic...
-
PT Solutions Named a USA TODAY Top Workplace for the Fifth Consecutive Year
ATLANTA--(BUSINESS WIRE)--PTS has been named a USA TODAY Top Workplace, recognizing the company's commitment to building a supportive, hospitality-driven community....
-
NEUPATH HEALTH TO PRESENT AT THE 2026 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE
TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”) operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services markets, today announced that Stephen Lemieux, CEO, will present and participate in one-on-one meetings at the 2026 Bloom Burton & Co. Healthcare Investor Conference to be held...
-
Blaine Labs, Inc Issues Voluntary Nationwide Recall of Wound Care Gel Products Due to Microbial Contamination
SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Blaine Labs, Inc. is voluntarily recalling three (3) lot numbers of Wound Care Gel products, 1 oz. & 3 oz. (0.1% Benzalkonium Chloride) to the consumer level due to microbial contamination. The affected product has been found to contain Lysinibacillus fusiformis, an environmental organism. Risk Statement This voluntary recall has been initiated as a precautionary measure due to the detection of microbial presence. The tested samples identified the...
-
Acadia Healthcare Announces Date for First Quarter 2026 Earnings Release
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its first quarter 2026 results on Wednesday, April 29, 2026, after the close of the market. Acadia will also conduct a conference call with institutional investors and analysts on Thursday, April 30, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the conference...
-
SPRY Launches First AI Scribe Agent Built Natively for Rehab Therapy: Learns Clinician Preferences, Carries Full Patient History, and Drives 80% Therapist Retention
SAN FRANCISCO--(BUSINESS WIRE)--SPRY launches Agentic Scribe for rehab therapy, with clinics reporting up to 75% faster documentation and revenue growth within 90 days....
-
Epia Neuro Launches to Develop Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline
SAN FRANCISCO--(BUSINESS WIRE)--Epia Neuro Launches to Develop Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline...
-
restor3d Announces Full Commercial Release of the Aeros™ Modular Stem System
DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in 3D-printed, personalized orthopedic solutions, today announced the full commercial availability of the Aeros™ Modular Stem System, an advancement in stemmed total ankle replacement designed to enhance implant stability, preserve bone, and improve surgical efficiency. The system follows a successful limited market release that began May 5, 2025, during which more than 250 procedures were completed across 50+ unique surgeons with strong feedbac...
-
NEUPATH HEALTH ANNOUNCES PROPOSED SHARES FOR DEBT SETTLEMENT
TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”) operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services markets, announced today that it intends to settle an aggregate amount of $420,000 of indebtedness (the “Debt”) owing to Joseph Walewicz, the Company’s former Chief Executive Offic...
-
TruBridge Announces Fourth Quarter and Full Year 2025 Results
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG) (“TruBridge”), a leading provider of healthcare technology solutions for rural and community hospitals, today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter Financial 2025 Highlights All comparisons are to the quarter ended December 31, 2024, unless otherwise noted. Total bookings of $19.8 million compared to $14.3 million Total revenue of $87.2 million compared to $88.1 million Re...